GAMCO Merger Arbitrage Class A USD

Reference Data

ISIN LU0687943745
Valor Number 14115190
Bloomberg Global ID
Fund Name GAMCO Merger Arbitrage Class A USD
Fund Provider GAMCO International SICAV SICAV Team
E-Mail: SicavInfo@gabelli.com
Phone: +1 914 921-5135
Web: gabelli.com/funds/sicavs
Fund Provider GAMCO International SICAV
Representative in Switzerland ACOLIN Fund Services AG
Zürich
Phone: +41 44 396 96 96
Distributor(s)
Asset Class Equities
EFC Category
Distribution Policy Accumulation
Home Country Luxembourg
Issuing Condition The fund does not charge any issuing commission and/or fees (units are issued at the NAV)
Redemption Condition The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV)
Investment Strategy *** The Sub-Fund’s primary objective is to invest in announced equity merger and acquisition transactions and maintain a diversified portfolio of transactions. The Sub-Fund seeks to achieve long term capital growth by engaging in risk arbitrage strategies.
Peculiarities

Fund Prices

Current Price * 15.51 USD 16.04.2025
Previous Price * 15.51 USD 15.04.2025
52 Week High * 15.89 USD 02.04.2025
52 Week Low * 14.57 USD 18.06.2024
NAV * 15.51 USD 16.04.2025
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 401,121,910
Unit/Share Assets *** 15,596,128
Trading Information SIX

Performance

YTD Performance +0.72% 31.12.2024
16.04.2025
YTD Performance (in CHF) -9.78% 31.12.2024
16.04.2025
1 month -1.55% 17.03.2025
16.04.2025
3 months -0.35% 16.01.2025
16.04.2025
6 months -0.23% 16.10.2024
16.04.2025
1 year +4.94% 16.04.2024
16.04.2025
2 years +7.08% 17.04.2023
16.04.2025
3 years +9.13% 19.04.2022
16.04.2025
5 years +28.10% 14.05.2020
16.04.2025

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

Hess Corp 5.93%
HashiCorp Inc Ordinary Shares Class A 5.13%
Kellanova Co 5.09%
COVESTRO AG-TEND 5.00%
Amedisys Inc 3.39%
Frontier Communications Parent Inc 3.29%
Intra-Cellular Therapies Inc 3.28%
Juniper Networks Inc 3.00%
Arcadium Lithium PLC 2.73%
Paragon 28 Inc 2.72%
Last data update 28.02.2025

Cost / Risk

TER *** 1.77%
TER date *** 31.12.2023
Performance Fee *** 20.00%
PTR
Max. Management Fee *** 1.50%
Ongoing Charges *** 1.76%
SRRI ***
SRRI date *** 31.03.2025

Breakdowns

Countries ***

Stock Sectors ***

Bond Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)